Your Finger Might Know Your Blood Sugar

No needle. No strip. Just a ring and 60 seconds. But is it actually telling you the truth?

Welcome Back,

For most people, checking blood sugar means a lancet, a test strip, and a small jolt of pain you learn to brace for. Singapore-based Actxa is betting that step can disappear entirely, replaced by a ring on your finger and a one-minute scan.

The company's Core Smart Ring made headlines this week after Fox News senior medical analyst Dr. Marc Siegel discussed it on "Fox & Friends," calling attention to its AI Glucose Scan feature, which the company says is the world's first non-invasive, clinically studied approach to everyday glucose awareness.

Today we look at how the ring actually works, what "clinically studied" does and doesn't mean here, and why the FDA wants you to pump the brakes before trusting any device like this with a real medical decision.

💍 How the Ring Actually Works

The Core Smart Ring doesn't pierce skin or draw blood. Instead, it uses photoplethysmography, or PPG, the same optical sensing tech found in most fitness trackers, to measure blood flow and pulse patterns through light absorption at the finger.

That raw optical signal on its own doesn't tell you much about blood sugar. The real work happens in Actxa's proprietary algorithm, called BGEM, short for Blood Glucose Evaluation and Monitoring, which analyzes hundreds of digital biomarkers extracted from the PPG signal and correlates the patterns with elevated glucose, according to Actxa's own announcement.

In practice, the scan takes about 60 seconds and returns one of two results, Normal or Elevated, a binary flag rather than a precise number like 110 mg/dL.

Results sync to Actxa's companion app, which turns raw sensor data into plain-language health insights.

🔬 What "Clinically Studied" Actually Means Here

Actxa describes BGEM as clinically backed, and the company isn't just relying on marketing copy to say so. A registered clinical trial listed on ClinicalTrials.gov describes an ongoing study in Indonesia collecting PPG data from roughly 500 individuals with diabetes and 400 healthy or undiagnosed participants, aimed at validating BGEM as a blood glucose prediction model in a Type 2 diabetes population.

A HardwareZone Singapore review of the Core ring also flagged something practical, the BGEM glucose feature requires regulatory approval in some markets and wasn't available in Singapore at the ring's own launch in August 2025, even though the hardware itself was for sale.

⚠️ The FDA's Blunt Warning

This is the part of the story that matters most. The U.S. Food and Drug Administration has issued a direct safety communication about this entire product category, warning consumers, patients, and caregivers about smartwatches and smart rings that claim to measure blood glucose without piercing the skin.

The FDA is explicit that this applies to any smartwatch or smart ring making this kind of claim, regardless of manufacturer or brand, and separately notes that watch or ring apps simply displaying data from an already-authorized continuous glucose monitor are a different, permitted category.

The FDA's guidance is aimed squarely at preventing dangerous treatment decisions based on unverified readings.

📊 Wellness Signal, Not a Medical Number

Independent analysis of this device category backs up why the FDA is being cautious. A 2026 industry guide on non-invasive glucose smart rings found accuracy rates around 70 to 85% under ideal conditions, sufficient for general wellness awareness but explicitly insufficient for diabetes treatment decisions.

That framing lines up with how Actxa itself positions the Core ring, not as a diagnostic tool, but as an early-awareness nudge. If a scan flags Elevated, the guidance is to see a doctor and confirm with a real medical test, not to treat the ring's reading as the diagnosis itself.

This is also part of a much bigger wave. Competing efforts, from Nano Miracle's near-infrared ring in Korea to Circular's planned Ring 2 glucose feature, are all racing toward the same non-invasive goal, and all facing the same accuracy ceiling for now.

⚖️ Wellness Trend vs. Medical Device

It's worth being precise about which category this ring actually falls into, because the marketing language and the regulatory reality don't always match up cleanly.

None of that erases the potential value here. It just means the ring's real job is prompting someone who's never thought about their blood sugar to start paying attention, not replacing the tools that actually manage diabetes.

For most healthy adults, the ring's value is awareness, not diagnosis.

🧠 AI Spotlight Analysis

The Core Smart Ring is a genuinely interesting case study in how AI health wearables are actually supposed to be marketed and understood. It's not claiming to replace a glucometer, it's claiming to nudge people who've never once thought about their metabolic health into checking in on it, using a device they're already wearing.

That's a meaningfully different pitch than "measure your blood sugar without a needle," even if the two get blurred in headlines and press coverage. The FDA's warning exists precisely because that blur is where consumers can get hurt, someone skipping insulin or a real diagnosis because a wellness ring told them they were fine.

The honest read is that this is early-stage, promising technology wrapped in headlines that outrun what it's currently allowed to claim. That's not unusual for consumer health tech, it's just worth remembering the next time "historic debut" appears in a headline about a device that hasn't cleared regulatory review yet.

🔗 Sources and Further Reading

Thanks for reading AI Spotlight.

Our mission is simple: deliver clear, trustworthy, and actionable AI insights that help professionals stay ahead without the hype.